DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that Dr. Mark Pykett, Neoprobe’s Executive Vice President and Chief Development Officer, will deliver a presentation to institutional investors at the Cowen and Company 31st Annual Health Care Conference at 2:30PM on Monday, March 7, 2011 at The Boston Marriott Copley Place. The Cowen and Company Health Care Conference is a conference for institutional investors focused on private and emerging public life science companies.
